Quantcast

Latest DNA Chip Stories

2014-09-29 08:32:24

TORONTO, Sept. 29, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, is pleased to announce the appointment of Peter Winkley to Chairman of the Board of Directors of SQI, replacing Claude Ricks. Mr. Ricks will continue to serve as a Director on the Board and will continue to provide leadership to the Company. "We are very pleased...

2014-09-17 08:31:05

TORONTO, Sept. 17, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that its common shares have been approved for trading in the United States on the OTCQX marketplace ("OTCQX"). Trading is expected to commence on September 17, 2014 on the OTCQX under the symbol SQIDF. The Company will continue to trade on the TSX...

2014-08-22 08:24:57

TORONTO, Aug. 22, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has entered into a Master Service Agreement to contract with a UK-based company to automate their DNA-based pathogen detection assays. During the initial phase of this agreement, SQI will be paid to deliver an automated working prototype of one of the...

2014-08-18 20:22:04

- Management to comment on SQI's commercial progress and opportunities - TORONTO, Aug. 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it will hold an investor conference call on Friday, August 22 at 2:00 pm ET. During the call, Andrew Morris, CEO, will provide a brief review of SQI's recent commercialization progress and...

2014-08-06 08:34:09

- Commercialization Progress Continues with Global Pharmaceutical Companies - TORONTO, August 6, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today reported fiscal and operational results for its fiscal third quarter, ended June 30(th), 2014. "During the third quarter we announced our fifth customer for our custom multiplex antibody assays,...

2014-07-15 16:26:57

- Addition of Dr. Allan Pronovost Strengthens US Commercialization Strategy - TORONTO, July 15, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it has appointed Dr. Allan Pronovost to its Board of Directors. SQI will also retain the services of Dr. Pronovost, as strategic advisor, where he will assist the Company in its efforts...

2014-06-27 08:25:55

DUBLIN, June 27, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vtcjzz/molecular) has announced the addition of the "2014 Report on the International Molecular Diagnostics (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) Market - Forecasts to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This market is poised to grow at a CAGR of 15.1% from...

2014-06-15 23:00:10

Increasing government funding and technological advancements are expected to positively influence the Genomics market growth - http://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html. (PRWEB) June 16, 2014 New analysis from MarketsandMarkets "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) -...

2014-06-07 12:21:15

RnRMarketResearch.com adds Molecular Diagnostics Markets for Genetic Testing, Cancer Testing & Infectious Disease Testing techniques. Report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. DALLAS, June 7, 2014 /PRNewswire-iReach/ -- The technologies that constitute molecular diagnostics-like first-generation amplification, DNA probes, fluorescent in...

2014-05-20 08:34:36

TORONTO, May 20, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it is being paid by one of the ten largest pharmaceutical companies in the world to develop and validate two custom multiplex anti-drug-antibody ("ADA") assays. This new customer will evaluate these two products using an established drug from its portfolio in order...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.